Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21146 studies found for:    T
Show Display Options
Rank Status Study
1 Terminated A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808
Condition: Alzheimers Disease
Intervention: Radiation: [F18] T808
2 Recruiting CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
Conditions: EphA2 Positive Malignant Glioma;   CAR-T Cell Immunotherapy
Intervention: Biological: CAR-T cell immunotherapy
3 Recruiting F 18 T807 Tau PET Imaging of Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: F 18 T807
4 Not yet recruiting CAR-T Hepatic Artery Infusions for CEA-Expressing Liver Metastases
Condition: Liver Metastases
Intervention: Biological: anti-CEA CAR-T cells
5 Terminated Trial of Second Generation Designer T Cells in Colorectal Carcinoma
Condition: Colorectal Cancer
Intervention: Biological: Gene Modified T Cells
6 Enrolling by invitation T-ABA Group Based Early Intervention For Parents of Children With ASD
Condition: Autism
Intervention: Behavioral: Targeted Applied Behavior Analysis (T-ABA)
7 Recruiting CAR-T Cell Immunotherapy for HCC Targeting GPC3
Conditions: GPC3 Positive Hepatocellular Carcinoma;   CAR-T Cell Immunotherapy
Intervention: Biological: CAR-T cell immunotherapy
8 Recruiting Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer
Condition: Colorectal Carcinoma
Intervention: Biological: re-activated T cells
9 Recruiting Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation
Condition: Patients Undergoing Allogeneic Stem Cell Transplantation
Intervention: Biological: CMV/EBV specific T-cell
10 Completed Assessment of the Clinical Efficacy and Acceptability of Think Positive (T+) in Diabetes Management
Condition: Diabetes (Insulin-requiring, Type 1 or Type 2)
Intervention: Device: Mobile phone telehealth application: Think Positive (T+)
11 Completed CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells
Condition: Liver Metastases
Intervention: Biological: anti-CEA 2nd generation designer T cells
12 Completed Home-based Program "T&E" for Fall Prevention and QoL in Elderly: a Randomised Control Pilot-study
Condition: Accidental Falls
Interventions: Other: T&E;   Other: OTAGO
13 Recruiting Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention: Biological: Third generation CAR-T cells
14 Recruiting F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Drug: F 18 T807
15 Active, not recruiting CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases
Condition: Liver Metastases
Interventions: Biological: anti-CEA CAR-T cells;   Device: Sir-Spheres
16 Completed Acceleration and Relapse Prevention With Triiodothyronine (T3) as an Adjunct to Electroconvulsive Therapy (ECT)
Condition: Depression
Intervention: Drug: T3
17 Recruiting Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Other: Intra-tumoral T4 immunotherapy
18 Recruiting CD19-targeting CAR T Cells for B Cell Lymphoma
Condition: B Cell Lymphoma
Intervention: Biological: CD19-targeting CAR T Cells infusion
19 Completed Open Label Study of Sipuleucel-T
Condition: Prostate Cancer
Intervention: Drug: Sipuleucel-T
20 Recruiting Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies
Conditions: B-Cell Chronic Lymphocytic Leukemia;   Non-Hodgkin's Lymphoma
Intervention: Drug: T-cell therapy + Rituximab + IL-2

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.